Page 0104

DISEASE-SPECIFIC CANCER CONTROL

CANCER CONTROL 2014 103

References continued

9. Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, et al.

Cervical and oral cancer screening in India. Journal of medical screening 2006;13 Suppl

1:S35-8.

10. International Agency for Research on Cancer.

http://globocan.iarc.fr/pages/fact_sheets_population.aspx, 2012.

11. Sankaranarayanan R, Swaminathan R. Cancer Survival in Africa Asia the Caribbean and

Central America: IARC Scientific Publication, 2011.

12. Siegel R, Naishadham D, Jemal A. Cancer Statistics 2013. CA: a cancer journal for

clinicians 2013;63:11-30.

13. International Agency for Research on Cancer. http://survcan.iarc.fr./.

14. Australian Institute of Health and Welfare (AIHW) & National Breast and Ovarian

Cancer Centre (NBOCC). Breast Cancer in Australia: an overview, 2009. Cancer series

no. 50. Cat. no. CAN 46. Canberra: AIHW, 2009.

15. International Agency for Research on Cancer. http://globocan.iarc.fr/factsheet.asp,

2008.

16. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy

and hormonal therapy for early breast cancer on recurrence and 15-year survival: an

overview of the randomised trials. The Lancet 2005;365(9472):1687-717.

17. Hill DJ, Giles GG, Russell IS, Collins JP, Mapperson KJ. Management of primary,

operable breast cancer in Victoria. Medical Journal of Australia 1990;152(2):67-72.

18. Fisher B. From Halsted to prevention and beyond: advances in the management of

breast cancer during the twentieth century. Eur J Cancer 1999;35(14):1963-73.

19. Kirwan CC. Breast cancer screening: what does the future hold? BMJ 2013;346:f87.

20. Baum M. Harms from breast cancer screening outweigh benefits if death caused by

treatment is included. BMJ 2013;346:f385.

21. Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer

has had her "life saved" by that screening. Archives of internal medicine

2011;171(22):2043-6.

22. Bleyer A, Welch HG. Effect of three decades of screening mammography on breastcancer incidence. The

New England journal of medicine 2012;367(21):1998-2005.

23. Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic

screening, accounts for most of the observed breast cancer specific mortality

reductions in Australian women since the national screening program began in 1991.

Breast cancer research and treatment 2012;131(3):949-55.

24. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic

screening from age 40 years on breast cancer mortality at 10 years' follow-up: a

randomised controlled trial. The Lancet 2006;368(9552):2053-60.

25. EUROSCREEN Working Group. Summary of the evidence of breast cancer service

screening outcomes in Europe and first estimate of the benefit and harm balance sheet.

Med Screening 2012;19 (suppl 1):5-13.

26. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of

observational studies. BMJ 1998;316(7125):140-4.

27. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography

screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.

28. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of

overdiagnosis of invasive breast cancer associated with screening mammography.

Cancer Causes Control 2010;21(2):275-82.

29. Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute

2010;102(9):605-13.

30. Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has

led to substantial underestimation of overdiagnosis. British journal of cancer

2013;109(7):2014-9.

31. Welch HG. Overdiagnosis and mammography screening: the question is no longer

whether, but how often it occurs. BMJ 2009;339:b1425.

32. Vaidya JS, Wenz F, Bulsara M, et al, On Behalf Of The TARGIT Trialists' Group. Riskadapted targeted intraoperative

radiotherapy versus whole-breast radiotherapy for

breast cancer: 5-year results for local control and overall survival from the TARGIT-A

randomised trial. http://www.sciencedirect.com/science/

article/pii/S0140673613619509.

33. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer

incidence and mortality. Breast cancer research: BCR 2004;6(6):229-39.

34. Sankaranarayanan R, Swaminathan R. Cancer Survival in Africa Asia the Caribbean and

Central America. IARC Scientific Publication, No 162 2011.

35. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, et al. Results of intermediate

measures from a population-based, randomized trial of mammographic screening

prevalence and detection of breast carcinoma among Asian women: the Singapore

Breast Screening Project. Cancer 1998;82(8):1521-8.

36. McPherson K. Screening for breast cancer--balancing the debate. BMJ

2010;340(jun24):c3106.

37. White V, Pruden M, Giles G, Collins J, Jamrozik K, Inglis G, et al. The management of

early breast carcinoma before and after the introduction of clinical practice guidelines.

Cancer 2004;101(3):476-85.

38. Cancer Australia. http://canceraustralia.gov.au/publications-and-resources/positionstatements/early-detection-breast-cancer.

39. Byrne MJ, Jamrozik K, Parsons RW, Fitzgerald CJ, Dewar JM, Harvey JM, et al. Breast

cancer in Western Australia in 1989. II. Diagnosis and primary management. ANZ

Journal of Surgery 1993;63:7-23.

40. Hill DJ, Jamrozik K, White VM, Collins JP, Boyages J, Shugg D, et al. Surgical

management of breast cancer in Australia in 1995. Kings Cross NSW: National Breast

Cancer Centre, 1999.

41. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening

programme on mortality from breast cancer in England and Wales, 1990-8: comparison

of observed with predicted mortality. BMJ 2000;321:665-69.

42. Kalager M, Zelen M, Langmark F, Adamai H. Effect of screening mammography on

breast cancer mortality in Norway. New England Journal of Medicine 2010;263:1203-10.

43. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring

European countries with different levels of screening but similar access to treatment:

trend analysis of WHO mortality database. BMJ 2011;343:d4411.

44. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of

breast self-examination in Shanghai: final results. Journal of the National Cancer Institute

2002;94(19):1445-57.

45. Semiglazov VF, Manikhas AG, Moiseenko VM, Protsenko SA, Kharikova RS, Seleznev IK,

et al. [Results of a prospective randomized investigation [Russia (st.petersburg)/WHO]

to evaluate the significance of self-examination for the early detection of breast

cancer]. Voprosy onkologii 2003;49(4):434-41.

46. U.S. Preventive Services Task Force. Clinical Guidelines: Screening for Breast Cancer:

U.S. Preventive Services Task Force Recommendation Statement Annals of internal

medicine 2009;151:716-26.

47. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year

results of a randomized trial in women aged 50-59 years. Journal of the National Cancer

Institute 2000;92(18):1490-9.

48. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, et al. A cluster randomized,

controlled trial of breast and cervix cancer screening in Mumbai, India: methodology

and interim results after three rounds of screening. International journal of cancer.

Journal international du cancer 2010;126(4):976-84.

49. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation

for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in

Sarawak, Malaysia. Annals of oncology: official journal of the European Society for

Medical Oncology / ESMO 2007;18(7):1172-6.

50. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. Relevance of breast

cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen:

patient-level meta-analysis of randomised trials. Lancet 2011;378(9793):771-84.

51. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. Comparisons between

different polychemotherapy regimens for early breast cancer: meta-analyses of longterm outcome among 100,000 women in 123 randomised

trials. Lancet

2012;379(9814):432-44.

52. Burton R, Bell R. The global challenge of reducing breast cancer mortality. The oncologist

2013;18(11):1200-2.

53. http://www.who.int/cancer/modules/en/index.html.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122
  123. Page 0123
  124. Page 0124
  125. Page 0125
  126. Page 0126
  127. Page 0127
  128. Page 0128
  129. Page 0129
  130. Page 0130
  131. Page 0131
  132. Page 0132
  133. Page 0133
  134. Page 0134
  135. Page 0135
  136. Page 0136
  137. Page 0137
  138. Page 0138
  139. Page 0139
  140. Page 0140
  141. Page 0141
  142. Page 0142
  143. Page 0143
  144. Page 0144
  145. Page 0145
  146. Page 0146
  147. Page 0147
  148. Page 0148
  149. Page 0149
  150. Page 0150
  151. Page 0151
  152. Page 0152
  153. Page 0153
  154. Page 0154
  155. Page 0155
  156. Page 0156

powered by PageTiger